PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10190517-11	1999	HDL3 cholesterol showed a persistent elevation during simvastatin treatment.	Simvastatin	54-65	HDL3	Homo sapiens	0-4	
1596304-7	1992	On a high fat diet, simvastatin produced almost no rise in HDL3 cholesterol whereas on a low fat diet HDL3 cholesterol was increased by 8.8% with simvastatin.	Simvastatin	146-157	HDL3	Homo sapiens	102-106	
1789812-8	1991	Our results suggest a conversion of HDL3 into HDL2, which could imply a beneficial effect of simvastatin upon the so-called reverse cholesterol transport, in addition to the striking reduction in atherogenic lipoproteins.	Simvastatin	93-104	HDL3	Homo sapiens	36-40	
2502417-6	1989	Mean plasma HDL cholesterol concentration and the subfractions HDL2 and HDL3 cholesterol were significantly increased by simvastatin.	Simvastatin	121-132	HDL3	Homo sapiens	72-76	
11282093-6	2001	Simvastatin led to an increase in LpAI-HDL(3) and did not change significantly LpAI-HDL(2) particle concentration.	Simvastatin	0-11	HDL3	Homo sapiens	39-45	
7857367-5	1994	Gender differences in the effect of simvastatin on HDL were confined to HDL3 cholesterol, although the drug raised HDL2 in both sexes on the low fat diet.	Simvastatin	36-47	HDL3	Homo sapiens	72-76	
7857367-6	1994	Simvastatin was responsible for an 11% increase in HDL3 cholesterol in men particularly when on a low fat diet but did not affect HDL3 in women.	Simvastatin	0-11	HDL3	Homo sapiens	51-55